Extramedullary hematopoiesis

Last revised by Dr Fabio Macori on 03 Sep 2021

Extramedullary hematopoiesis is a response to the failure of erythropoiesis in the bone marrow.

This article aims to a general approach on the condition, for a dedicated discussion for a particularly involved organ, please refer to the specific articles on: 

Extramedullary hematopoiesis usually affects visceral organs like liver, spleen, lymph nodes and involves thorax. Less commonly it can affect the pleura, lungs, gastrointestinal tract, breast, skin, brain, kidneys, and adrenal glands.

  • most common: diffuse visceromegaly (splenomegaly and hepatomegaly)
    • best evaluated with ultrasound, CT or MRI
    • lesions are typically hypermetabolic, hence FDG-18 PET avid 4
  • rarely, can result in focal masses in liver and spleen that need to be differentiated from malignancy
  • most common intrathoracic finding is a posterior mediastinal mass
    • may be either unilateral or bilateral
    • smooth, sharply-delineated, often lobulated margins
    • fat can be seen, if chronic
    • calcification is very atypical
  • other than this, within the thorax, there can be rib expansion and rarely pulmonary infiltrates 4
  • perirenal soft tissue with normal renal contour can be seen (mimicking lymphoma or Erdheim-Chester disease like appearance) 4. It has been found to be the most common retroperitoneal finding 4
  • focal or diffuse peritoneal nodules can be seen 4
  • can present as pre-sacral soft tissue mass 4
  • epidural soft tissue masses with peripheral fat can be seen in spinal cord or CNS with compression of spinal cord 4
  • lobulated mass with soft tissue attenuation 7
  • areas of fat attenuation, if macroscopic fat is present 7
  • attenuation of lesion is more than that of a skeletal muscle, in case of repeated blood transfusions 7

Signal characteristics of extramedullary hematopoiesis are 7:

  • T1
    • intermediate signal intensity
    • low signal intensity due to massive iron deposition in repeated transfusions

 

  • T1 C+ (Gd)
    • variable enhancement 
    • no enhancement in case of massive iron deposition
  • T2
    • intermediate to high signal intensity (relative to skeletal muscle)
    • low signal intensity due to massive iron deposition in repeated transfusions

These masses are generally hypervascular with high chances of occurrence of bleeding as a complication of biopsy. Hence, avoid biopsy near vital structures like spinal cord to avoid risk of spinal cord compression. FNAC is a better option at such sites 4. For treatment, giving radiotherapy on the involved site or excision of the mass or multiple blood transfusions to decrease extramedullary hematopoiesis can be done 4.

ADVERTISEMENT: Supporters see fewer/no ads

Cases and figures

  • Case 1: in thalassemia
    Drag here to reorder.
  • Case 1: in thalassemia
    Drag here to reorder.
  • Case 2: in thalassemia
    Drag here to reorder.
  • Case 3: in thalassemia
    Drag here to reorder.
  • Case 4
    Drag here to reorder.
  • Case 5
    Drag here to reorder.
  • Case 6
    Drag here to reorder.
  • Case 7: in the adrenal gland
    Drag here to reorder.
  • Case 8
    Drag here to reorder.
  • Case 9: peritoneal
    Drag here to reorder.
  • Case 10
    Drag here to reorder.
  • Case 11 : MRI
    Drag here to reorder.
  • Case 12: thalassemia
    Drag here to reorder.
  • Case 13
    Drag here to reorder.
  • Case 14: extramedullary hematopoiesis of the spleen
    Drag here to reorder.
  • Case 15: Extramedullary hematopoiesis as a presacral mass in Axial CT
    Drag here to reorder.
  • Case 15: Extramedullary hematopoiesis as a presacral mass in MRI
    Drag here to reorder.
  • Updating… Please wait.

     Unable to process the form. Check for errors and try again.

     Thank you for updating your details.